메뉴 건너뛰기




Volumn 33, Issue 12, 2010, Pages 1117-1133

An experimental investigation of masking in the US FDA adverse event reporting system database

Author keywords

Pharmacovigilance; Postmarketing surveillance; Statistics

Indexed keywords

ARTICLE; DATA BASE; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; MASKING; PATIENT SAFETY; PRIORITY JOURNAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 78549253881     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11584390-000000000-00000     Document Type: Article
Times cited : (49)

References (16)
  • 1
    • 0141729306 scopus 로고    scopus 로고
    • Practical pharmacovigilance analysis strategies
    • Gould AL. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Saf 2003; 12: 559-74
    • (2003) Pharmacoepidemiol Drug Saf , vol.12 , pp. 559-74
    • Gould, A.L.1
  • 2
    • 26944491481 scopus 로고    scopus 로고
    • Perspectives on the use of data mining in pharmacovigilance
    • Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf 2005; 28 (11): 981-1007
    • (2005) Drug Saf , vol.28 , Issue.11 , pp. 981-1007
    • Almenoff, J.1    Tonning, J.M.2    Gould, A.L.3
  • 3
    • 78549259368 scopus 로고    scopus 로고
    • EMEA Eudravigilance Expert Working Group (EV-EWG) 26 June London. Doc. Ref. EMEA/106464/2006 rev.1 [online]. Available Accessed 2010 Sep 6
    • EMEA Eudravigilance Expert Working Group (EV-EWG). Guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system, 26 June 2008. London. Doc. Ref. EMEA/106464/2006 rev.1 [online]. Available from URL http://www.ema.europa.eu/docs/en- GB/document-library/ Regulatory-and-procedural-guide line/2009/11/WC500011434.pdf [Accessed 2010 Sep 6].
    • (2008) Guideline on the Use of Statistical Signal Detection Methods in the Eudravigilance Data Analysis System
  • 4
    • 24344432126 scopus 로고    scopus 로고
    • The role of data mining in pharmacovigilance
    • Sep
    • Hauben M, Madigan D, Gerrits CM, et al. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005 Sep; 4 (5): 929-48
    • (2005) Expert Opin Drug Saf , vol.4 , Issue.5 , pp. 929-48
    • Hauben, M.1    Madigan, D.2    Gerrits, C.M.3
  • 5
    • 52449124309 scopus 로고    scopus 로고
    • The importance of reporting negative findings in data mining: The example of exenatide and pancreatitis
    • Hauben M, Hochberg A. The importance of reporting negative findings in data mining: the example of exenatide and pancreatitis. Pharmaceut Med 2008; 22 (4): 215-9
    • (2008) Pharmaceut Med , vol.22 , Issue.4 , pp. 215-9
    • Hauben, M.1    Hochberg, A.2
  • 6
    • 73649129173 scopus 로고    scopus 로고
    • Quantitative signal detection for vaccines: Effects of stratification, background and masking on GlaxoSmithKline's spontaneous reports database
    • Zeinoun Z, Seifert H, Verstraeten T. Quantitative signal detection for vaccines: effects of stratification, background and masking on GlaxoSmithKline's spontaneous reports database. Hum Vaccines 2009; 5 (9): 599-607
    • (2009) Hum Vaccines , vol.5 , Issue.9 , pp. 599-607
    • Zeinoun, Z.1    Seifert, H.2    Verstraeten, T.3
  • 7
    • 60749099873 scopus 로고    scopus 로고
    • Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions
    • Hauben M, Aronson JK. Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf 2009; 32 (2): 99-110
    • (2009) Drug Saf , vol.32 , Issue.2 , pp. 99-110
    • Hauben, M.1    Aronson, J.K.2
  • 8
    • 33644926443 scopus 로고    scopus 로고
    • Response to letter by Levine et al
    • Hauben M, Reich L. Response to letter by Levine et al. Br J Clin Pharmacol 2005; 61 (1): 115-7
    • (2005) Br J Clin Pharmacol , vol.61 , Issue.1 , pp. 115-7
    • Hauben, M.1    Reich, L.2
  • 9
    • 35148890461 scopus 로고    scopus 로고
    • Using data mining to predict safety actions from FDA adverse event reporting system data
    • Hochberg AM, Reisinger SJ, Pearson RK, et al. Using data mining to predict safety actions from FDA adverse event reporting system data. Drug Inf J 2007; 41 (5): 633-44
    • (2007) Drug Inf J , vol.41 , Issue.5 , pp. 633-44
    • Hochberg, A.M.1    Reisinger, S.J.2    Pearson, R.K.3
  • 10
    • 77953568356 scopus 로고    scopus 로고
    • A decade of data mining and still counting
    • Hauben M, Noren GN. A decade of data mining and still counting. Drug Saf 2010; 33 (7): 527-34
    • (2010) Drug Saf , vol.33 , Issue.7 , pp. 527-34
    • Hauben, M.1    Noren, G.N.2
  • 11
    • 34548700834 scopus 로고    scopus 로고
    • Data mining in pharmacovigilance: Computational cost as a neglected performance parameter
    • Hauben M, Madigan D, Hochberg AM, et al. Data mining in pharmacovigilance: computational cost as a neglected performance parameter. Int J Pharm Med 2007; 21 (5): 319-23
    • (2007) Int J Pharm Med , vol.21 , Issue.5 , pp. 319-23
    • Hauben, M.1    Madigan, D.2    Hochberg, A.M.3
  • 12
    • 78549296716 scopus 로고    scopus 로고
    • Large scale regressionbased pattern discovery: The example of screening the WHO global drug safety data base
    • Caster O, Noren GK, Madigan D, et al. Large scale regressionbased pattern discovery: the example of screening the WHO global drug safety data base. Stat Anal Data Min 2010; 3 (4): 197-208
    • (2010) Stat Anal Data Min , vol.3 , Issue.4 , pp. 197-208
    • Caster, O.1    Noren, G.K.2    Madigan, D.3
  • 13
    • 34748847390 scopus 로고    scopus 로고
    • Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: The notoriety bias
    • Pariente A, Gregoire F, Fourrier-Reglat A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf 2007; 30 (10): 891-8
    • (2007) Drug Saf , vol.30 , Issue.10 , pp. 891-8
    • Pariente, A.1    Gregoire, F.2    Fourrier-Reglat, A.3
  • 14
    • 34249896410 scopus 로고    scopus 로고
    • 'Extreme duplication' in the US FDA Adverse Events Reporting System Database
    • Hauben M, Reich L, DeMicco J, et al. 'Extreme duplication' in the US FDA Adverse Events Reporting System Database. Drug Saf 2007; 30 (6): 551-4
    • (2007) Drug Saf , vol.30 , Issue.6 , pp. 551-4
    • Hauben, M.1    Reich, L.2    Demicco, J.3
  • 15
    • 34548644680 scopus 로고    scopus 로고
    • Interexpert agreement of seven criteria in causality assessment of adverse drug reactions
    • Oct
    • Arimone Y, Miremont-Salame G, Haramburu F, et al. Interexpert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 2007 Oct; 64 (4): 482-8
    • (2007) Br J Clin Pharmacol , vol.64 , Issue.4 , pp. 482-8
    • Arimone, Y.1    Miremont-Salame, G.2    Haramburu, F.3
  • 16
    • 0142244575 scopus 로고    scopus 로고
    • Omeprazole-induced intractable cough
    • Howalzi M, Delafosse C. Omeprazole-induced intractable cough. Ann Pharmacother 2003; 37: 1607-9
    • (2003) Ann Pharmacother , vol.37 , pp. 1607-9
    • Howalzi, M.1    Delafosse, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.